Structure of HIV-1 gp41 with its Membrane Anchors Targeted by Neutralizing Antibodies

The HIV-1 gp120/gp41 trimer undergoes a series of conformational changes in order to catalyze gp41-induced fusion of viral and cellular membranes. Here, we present the crystal structure of gp41 locked in a fusion intermediate state by an MPER-specific neutralizing antibody. The structure illustrates...

ver descrição completa

Detalhes bibliográficos
Autores: Caillat, Christophe, Guilligay, Delphine, Torralba Iturbe, Johana, Friedrich, Nikolas, Nieva Escandón, José Luis, Trkola, Alexandra, Chipot, Christophe J., Dehez, Francois L., Weissenhorn, Winfried
Formato: artículo
Fecha de publicación:2021
País:España
Recursos:Universidad del País Vasco
Repositorio:Addi. Archivo Digital para la Docencia y la Investigación
OAI Identifier:oai:addi.ehu.eus:10810/51495
Acesso em linha:http://hdl.handle.net/10810/51495
Access Level:acceso abierto
Palavra-chave:gp41-induced fusion
viral and cellular membranes
crystal structure of gp41 locked
fusion peptide
transmembrane
hydrophobic core
neutralizing antibodies
Descrição
Resumo:The HIV-1 gp120/gp41 trimer undergoes a series of conformational changes in order to catalyze gp41-induced fusion of viral and cellular membranes. Here, we present the crystal structure of gp41 locked in a fusion intermediate state by an MPER-specific neutralizing antibody. The structure illustrates the conformational plasticity of the six membrane anchors arranged asymmetrically with the fusion peptides and the transmembrane regions pointing into different directions. Hinge regions located adjacent to the fusion peptide and the transmembrane region facilitate the conformational flexibility that allows high-affinity binding of broadly neutralizing anti-MPER antibodies. Molecular dynamics simulation of the MPER Ab-stabilized gp41 conformation reveals a possible transition pathway into the final post-fusion conformation with the central fusion peptides forming a hydrophobic core with flanking transmembrane regions. This suggests that MPER-specific broadly neutralizing antibodies can block final steps of refolding of the fusion peptide and the transmembrane region, which is required for completing membrane fusion.